Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Intervalo de ano de publicação
1.
Intern Med J ; 54(8): 1376-1383, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38816941

RESUMO

BACKGROUND: Amid concerns about severe COVID-19 in patients with autoimmune rheumatic disease (AIRD) during the outbreak, it is crucial to explore behavioural changes, whether healthy or unhealthy, arising from this patient population in response to the changing healthcare environment. AIM: To investigate COVID-19-driven behavioural changes in patients with AIRD. METHODS: This observational study invited patients who attended the rheumatology clinic of the Korle Bu Teaching Hospital from 1 August 2020 to 1 July 2021, to respond to a survey questionnaire distributed on the patient's WhatsApp platform. Variables observed were changes in patient behaviour and decision-making related to medication, healthcare service utilisation and clinical advice. RESULTS: Results for 233 patients were analysed in the study, the majority (89.7%) of whom were women. The most significant behavioural changes were a reduction in hydroxychloroquine (HCQ) dosage, adoption of telemedicine for clinical consultation and keen adherence to protective/preventive health measures. Patients also expressed anxiety regarding the risk of contracting COVID-19 (52.5%), infecting their families (66.5%) and losing income (50.2%) due to the pandemic. Women and students were more likely to engage in self-isolation/shielding behaviour. Employed participants practised social distancing more, reduced HCQ dosage and had more fear of losing income. Having mixed connective tissue disease is associated with being anxious about the risk of COVID-19 infection. CONCLUSION: The COVID-19 pandemic has resulted in behaviour changes among patients with AIRD. Despite the perceived risk, most of these patients continue to adhere to their prescribed medication regimens, especially maintaining the dosage of traditional immunosuppressive agents.


Assuntos
Doenças Autoimunes , COVID-19 , Doenças Reumáticas , Humanos , COVID-19/epidemiologia , COVID-19/psicologia , COVID-19/prevenção & controle , Feminino , Masculino , Doenças Reumáticas/epidemiologia , Doenças Reumáticas/tratamento farmacológico , Doenças Reumáticas/psicologia , Pessoa de Meia-Idade , Doenças Autoimunes/epidemiologia , Doenças Autoimunes/psicologia , Adulto , Idoso , Inquéritos e Questionários , Hidroxicloroquina/uso terapêutico , Telemedicina , Comportamentos Relacionados com a Saúde , Antirreumáticos/uso terapêutico , Adulto Jovem , Pandemias
2.
J Nutr Health Aging ; 28(5): 100246, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38669857

RESUMO

The global increase in the population of older persons has profound inter-sectoral implications, necessitating the development of age-friendly initiatives at the global and national levels. While progress has been relatively slower across Sub-Saharan African countries, highlighting existing commendable initiatives is essential to identify the current gaps and promote the development of strategies and interventions to promote age-friendly societies. This mini-review highlights some of the key initiatives in Ghana in the areas of policy, healthcare, finance, social services, education and research and in promoting dementia-friendly communities.


Assuntos
Demência , Humanos , Gana , Idoso , Envelhecimento , Promoção da Saúde , Política de Saúde , Serviço Social , Idoso de 80 Anos ou mais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA